Linezolid Tolerance During the BPaL Regimen With Dosage Personalization Based on Therapeutic Drug Monitoring (TDM) During Multidrug-Resistant Tuberculosis Treatment
Linezolid Tolerance During the BPaL Regimen With Dosage Personalization Based on Therapeutic Drug Monitoring (TDM) During Multidrug-Resistant Tuberculosis Treatment
Recruiting · NCT07477119 · Registry updated 2026-05-13Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Linezolid Tolerance During the BPaL Regimen With Dosage Personalization Based on Therapeutic Drug Monitoring (TDM) During Multidrug-Resistant Tuberculosis Treatment | Actinomycetales infectious disease, Bacterial Infections and Mycoses, Chemically-Induced Disorders, Drug-Related Side Effects and Adverse Reactions, Infections, bacterial infectious disease, gram-positive bacterial infections, multidrug-resistant tuberculosis, mycobacterial infectious disease, nervous system disorder, neuromuscular disease, peripheral nervous system disorder, tuberculosis | Recruiting | Phase 4 | 2026-05-13 | NCT07477119 |
4 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| ASST Fatebenefratelli Sacco | 19 |
| Damien Foundation | 2 |
| Marco Schiuma | 1 |
| University of Milan | 55 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Centre de Santé de Tombolia | Conakry | Guinea | 1 |